CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832273741
- Phone
- 1-866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- 4 Open-market buy Director bought 7,111 shares at $3.50 ($24,889)
- 4 Open-market buy Director bought 314,561 shares at an average $2.40 ($754,737)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 100,375 shares (grant or award)
- 4 Planned sale President and CEO sold 20,618 shares at $1.22 ($25,154)
- 4 Option exercise Director acquired 25,094 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Planned sale SVP, Finance & CAO sold 1,242 shares at $1.24 ($1,540)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 6 · 119 filings